Antidepressants not tied to stunted infant growth

By Kathryn Doyle NEW YORK (Reuters Health) – Despite concerns that antidepressant use during pregnancy could affect infants’ growth and development, a small new study finds no size differences in the first year of life between babies exposed and not exposed to the drugs. The medications, known as selective serotonin reuptake inhibitors, or SSRIs, which include fluoxetine (marketed as Prozac) and citalopram (Celexa), have been tied to premature births and lower birth weight. But their affect on growth during infancy had not been studied. …